Cite
HARVARD Citation
Silverman, M. et al. (n.d.). A single‐ and multiple‐ascending dose study to evaluate the safety and pharmacokinetics of oral PU‐AD, an epichaperome inhibitor to treat Alzheimer's disease. Alzheimer's & dementia. p. n/a. [Online].